Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)

NCT00595231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: SYN111
DRUG: Placebo

Sponsor

Biotie Therapies Inc.

Collaborators

[object Object]